Reference48 articles.
1. Jamieson, D.G., Parekh, A., and Ezekowitz, M.D. (2005) Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents J Cardiovasc Pharmacol Ther
10, 153–61.
2. Collaboration, A.T. (1994) Collaborative overview of randomised trials of antiplatelet therapy – I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ
308, 81–106.
3. Fitzgerald, D.J., Roy, L., Catella, F., and FitzGerald, G.A. (1986) Platelet activation in unstable coronary disease N Eng J Med
315, 983–9.
4. Fuster, V. (1981) Role of platelets in the development of atherosclerotic disease and possible interference with platelet inhibitor drugs Scand J Haematol Suppl 38, 1–38.
5. Hamm, C.W., Lorenz, R.L., Bleifeld, W., Kupper, W., Wober, W., and Weber, P.C. (1987) Biochemical evidence of platelet activation in patients with persistent unstable angina J Am Coll Cardiol
10, 998–06.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. OBSOLETE: Microvasculature in Health and Disease;Reference Module in Biomedical Sciences;2018
2. Microvasculature in Health and Disease;Encyclopedia of Cardiovascular Research and Medicine;2018